Auna S.A. Class A (AUNA)
NYSE:AUNA
Want to see AUNA full AI Analyst Report?
AUNA Stock Chart & Stats
$4.99
$0.02(0.29%)
At close: 4:00 PM EST
$4.99
$0.02(0.29%)
Day’s Range― - ―
52-Week Range$4.09 - $6.85
Previous CloseN/A
Volume1.62K
Average Volume (3M)446.37K
Market Cap
$375.99M
Enterprise Value$4.68B
Total Cash (Recent Filing)$428.92M
Total Debt (Recent Filing)$3.82B
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Aug 26, 2026EPS Estimate
0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding30,095,388
10 Day Avg. Volume235,431
30 Day Avg. Volume446,366
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)0.31
Price to Sales (P/S)0.11
P/FCF Ratio3.08
Enterprise Value/Market Cap12.45
Enterprise Value/Revenue1.04
Enterprise Value/Gross Profit2.73
Enterprise Value/Ebitda5.92
Forecast
1Y Price Target
$5.00Price Target Upside0.20% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)3.01
Revenue Forecast (FY)$4.77B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationAuna’s materially stronger operating cash flow (~$601M TTM) and sizable free cash flow (~$493M TTM, with Q1 FCF up 2.6x YoY) provide durable capacity to service debt, fund strategic projects and reinvest in high‑complexity services. Consistent FCF improves financial optionality and supports medium‑term deleveraging plans.
Solid Operating Profitability (EBIT)Auna’s ~17.7% EBIT margin reflects a durable recovery in core hospital and clinic economics after prior losses, indicating the business can generate healthy operating returns. This structural margin strength underpins cash flow, funds reinvestment into high‑complexity care and supports sustainable operating performance across cycles.
Diversified Regional Platform & Payer Mix GainsAuna’s multi‑country footprint and improving payer mix (greater risk‑sharing, more new payers and expanding OncoSalud memberships) reduce reliance on single markets and create recurring revenue levers. Diversification plus higher‑complexity services expands addressable market and supports more resilient revenue streams long term.
Bears Say
High Leverage And Limited FlexibilityAuna’s elevated leverage (debt-to-equity ~2.28x and reported net leverage ~3.7x) constrains financial flexibility and leaves less cushion against operational setbacks. High gross debt means a significant portion of free cash flow must prioritize deleveraging and interest service, slowing capital allocation for growth or distributions.
Thin Net Margin And Earnings SensitivityDespite strong EBIT, a thin ~2.2% net margin signals earnings are vulnerable to FX, financing costs and one‑offs. Noncash FX losses and financing/tax items have driven net income swings, reducing retained earnings and limiting the company’s ability to absorb shocks or accelerate deleveraging without sustained operational improvement.
Operational Margin Pressure From Peru And PayrollPeru revenue reconciliations, delayed pharmacy rebates and rising payroll costs have produced recurring margin headwinds. These operational issues can persist through billing cycles and regulatory interactions, making near‑term margin normalization uneven and slowing conversion of top‑line growth into durable net income improvement.
Auna S.A. Class A News
AUNA FAQ
What was Auna S.A. Class A’s price range in the past 12 months?
Auna S.A. Class A lowest stock price was $4.09 and its highest was $6.85 in the past 12 months.
What is Auna S.A. Class A’s market cap?
Auna S.A. Class A’s market cap is $375.99M.
When is Auna S.A. Class A’s upcoming earnings report date?
Auna S.A. Class A’s upcoming earnings report date is Aug 26, 2026 which is in 62 days.
How were Auna S.A. Class A’s earnings last quarter?
Auna S.A. Class A released its earnings results on May 19, 2026. The company reported $0.026 earnings per share for the quarter, missing the consensus estimate of $0.182 by -$0.156.
Is Auna S.A. Class A overvalued?
According to Wall Street analysts Auna S.A. Class A’s price is currently Undervalued.
Does Auna S.A. Class A pay dividends?
Auna S.A. Class A does not currently pay dividends.
What is Auna S.A. Class A’s EPS estimate?
Auna S.A. Class A’s EPS estimate is 0.25.
How many shares outstanding does Auna S.A. Class A have?
Auna S.A. Class A has 30,095,388 shares outstanding.
What happened to Auna S.A. Class A’s price movement after its last earnings report?
Auna S.A. Class A reported an EPS of $0.026 in its last earnings report, missing expectations of $0.182. Following the earnings report the stock price went down -7.789%.
Which hedge fund is a major shareholder of Auna S.A. Class A?
Currently, no hedge funds are holding shares in AUNA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Auna S.A. Class A Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.00 (0.20% Upside)
$5.00 (0.20% Upside)
Blogger Sentiment
Bullish
AUNA Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 15.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $283.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-19.25%
12-Months-Change
Fundamentals
Return on Equity
4.10%
Trailing 12-Months
Asset Growth
14.08%
Trailing 12-Months
Company Description
Auna S.A. Class A
Auna S.A. operates as a healthcare services provider, overseeing a network of hospitals and clinics across Mexico, Peru, and Colombia. The company also offers prepaid medical programs in Peru, alongside dental and vision insurance plans for clients in Mexico. This organization was established in 1989 and maintains its corporate headquarters in Luxembourg.
AUNA Company Deck
AUNA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed clear topline momentum and meaningful improvements in cash generation, liquidity and payer mix across Mexico, Peru and Colombia, supported by rising high-complexity volumes and strategic wins (OncoSalud B2B growth, new payer contracts, Torre Trecca progress). However, near-term profitability was pressured by Peru revenue reconciliations and delayed pharmacy rebates, noncash FX losses, and higher compensation costs which caused a consolidated adjusted EBITDA decline and margin compression. Management reaffirmed full-year revenue and EBITDA guidance and expects stronger second-half performance, positioning the company to convert current operational momentum into margin recovery and deleveraging over 2026.View all AUNA earnings summariesAUNA Stock 12 Month Forecast
Average Price Target
$5.00
▲(0.20% Upside)
Technical Analysis
Sonida Senior Living
―
Community Health
―
Cross Country Healthcare
―
Talkspace
―
Airsculpt Technologies
―
Ownership Overview
― Insiders
4.60% Mutual Funds
8.40% Other Institutional Investors
83.22% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---